Bruton's Tyrosine Kinase—Going Beyond the B Cell
Immunology · 2026-08 · 178 (4) · 545-560
DOI: 10.1111/imm.70126 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 26.02.2026. Verfasst von Rochelle Y Benoit und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, B-Lymphocytes, Myeloid Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben.
Abstract (Originalsprache)
Bruton's Tyrosine Kinase (BTK) is a cytoplasmic kinase essential for B cell‐mediated signalling, yet has also received recent recognition as a direct regulator of myeloid cell function. Beyond its established role in B cell malignancies, BTK influences receptor‐driven activation in monocytes, macrophages, microglia, granulocytes, and other organ‐specific macrophages by influencing key molecular pathways involved in phagocytosis, inflammatory‐mediated signalling, and cell metabolism (e.g., NFκB, STAT3, and NLRP3). BTK inhibitors (BTKis) were initially developed and approved to treat B cell‐related cancers, however, they have also demonstrated significant therapeutic/clinical efficacy in autoimmune, allergic, and immune‐driven neuroinflammatory disorders, including rheumatoid arthritis, IgA nephropathy, multiple sclerosis, and chronic spontaneous urticaria. This review specifically addresses, compares, and summarises how BTK inhibition within distinct myeloid‐derived cell subsets alters inflammatory‐related phenotypes and functions within these cells. Together, providing cell‐specific insights into BTK as a central regulator of innate immunity and myeloid cell function may help generate significant translational potential for BTKis in multiple inflammatory‐mediated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
ORCID-Profile: Craig S Moore
Zitieren
APA
Benoit, R. Y., Loshi, S., & Moore, C. S. (2026). Bruton's Tyrosine Kinase—Going Beyond the B Cell. Immunology, 178(4), 545-560. https://doi.org/10.1111/imm.70126
Vancouver
Benoit RY, Loshi S, Moore CS. Bruton's Tyrosine Kinase—Going Beyond the B Cell. Immunology. 2026;178(4):545-560. doi:10.1111/imm.70126
BibTeX
@article{Benoit2026,
author = {Benoit, Rochelle Y and Loshi, Sheila and Moore, Craig S},
title = {Bruton's Tyrosine Kinase—Going Beyond the B Cell},
journal = {Immunology},
year = {2026},
volume = {178},
number = {4},
pages = {545--560},
doi = {10.1111/imm.70126}
}
EUVIMED